Superworth

Alphatec price to free cash flow ATEC

Market value divided by free cash flow over the last twelve months, since 2016.

Today, Nov 2, 2026
370×
Peer median
16.9×

Alphatec's price to free cash flow is 370× as of Nov 2, 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 16.9×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far370×164×370×
2025n/m a value too high to mean anything
2024n/m a value too high to mean anything
2023n/m a value too high to mean anything
2022n/m a value too high to mean anything
2021n/m a value too high to mean anything
2020n/m a value too high to mean anything
2019n/m a value too high to mean anything
2018n/m a value too high to mean anything
2017n/m a value too high to mean anything
2016100×61.9×247×

Against its peers

Companies in Medical - Instruments & Supplies nearest Alphatec's size, closest first, today.

CompanyPrice to free cash flow
ATECAlphatec370×
BVSBioventus11.7×
IARTIntegra Lifesciences12.3×
STAAStaar Surgicaln/m
IRMDIradimed38.9×
CDRECadre17.3×
EYENational Vision27.6×
MOVMovado10.0×
LMATLemaitre Vascular25.2×
INSPInspire Medical Systems16.6×
UFPTUFP Technologiesn/m
Peer median16.9×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Alphatec

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.